EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy

Xuan-De Zhu, Angela Corona iD, Stefania Maloccu, Enzo Tramontano iD, Shuai Wang iD, Christophe Pannecouque iD, Erik De Clercq iD, Ge Meng, Fen-Er Chen

Molecules · 2024

DOI: 10.3390/molecules29092120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Xuan-De Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Pyrimidines, Molecular Docking Simulation, Quantitative Structure-Activity Relationship, Anti-HIV Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, EU funding within the MUR PNRR Extended, RAS LR 7/07 project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ribonuclease H (RNase H) was identified as an important target for HIV therapy. Currently, no RNase H inhibitors have reached clinical status. Herein, a series of novel thiazolone[3,2-a]pyrimidine-containing RNase H inhibitors were developed, based on the hit compound 10i, identified from screening our in-house compound library. Some of these derivatives exhibited low micromolar inhibitory activity. Among them, compound 12b was identified as the most potent inhibitor of RNase H (IC50 = 2.98 μM). The experiment of magnesium ion coordination was performed to verify that this ligand could coordinate with magnesium ions, indicating its binding ability to the catalytic site of RNase H. Docking studies revealed the main interactions of this ligand with RNase H. A quantitative structure activity relationship (QSAR) was also conducted to disclose several predictive mathematic models. A molecular dynamics simulation was also conducted to determine the stability of the complex. Taken together, thiazolone[3,2-a]pyrimidine can be regarded as a potential scaffold for the further development of RNase H inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesMolecular Docking SimulationQuantitative Structure-Activity RelationshipAnti-HIV AgentsHumansMolecular Dynamics SimulationRibonuclease HDrug DesignHIV InfectionsHIV-1Enzyme InhibitorsThiazolesMolecular Structure

Stichwörter der Autor:innen

3D-QSARRNase Hallosteric inhibitorsthiazolone[3,2-a]pyrimidine

Substanzen

PyrimidinesAnti-HIV AgentsRibonuclease HEnzyme InhibitorsThiazoles

Autor:innen und Institutionen

  • Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry, Fudan University, Shanghai 200433, China.
  • Department of Life and Environmental Sciences, Department of Applied Science Biosyst, University of Cagliari, 09042 Cagliari, Italy.
  • Rega Institute for Medical Research, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.

ORCID-Profile: Angela Corona, Enzo Tramontano, Shuai Wang, Christophe Pannecouque, Erik De Clercq

Förderung

  • National Natural Science Foundation of China
  • EU funding within the MUR PNRR Extended
  • RAS LR 7/07 project

Zitieren

APA

Zhu, X. D., Corona, A., Maloccu, S., Tramontano, E., Wang, S., Pannecouque, C., De Clercq, E., Meng, G., & Chen, F. E. (2024). Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Molecules. https://doi.org/10.3390/molecules29092120

Vancouver

Zhu XD, Corona A, Maloccu S, Tramontano E, Wang S, Pannecouque C, et al. Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Molecules. 2024. doi:10.3390/molecules29092120

BibTeX
@article{Zhu2024,
  author = {Zhu, Xuan-De and Corona, Angela and Maloccu, Stefania and Tramontano, Enzo and Wang, Shuai and Pannecouque, Christophe and De Clercq, Erik and Meng, Ge and Chen, Fen-Er},
  title = {Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29092120}
}
Kostenlos starten →